Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sanofi (SNY) Other Operating Expenses (2023 - 2025)

Historic Other Operating Expenses for Sanofi (SNY) over the last 5 years, with Q4 2025 value amounting to -$5.2 billion.

  • Sanofi's Other Operating Expenses fell 4582.74% to -$5.2 billion in Q4 2025 from the same period last year, while for Dec 2025 it was -$9.8 billion, marking a year-over-year decrease of 8594.37%. This contributed to the annual value of -$5.0 billion for FY2025, which is 3976.5% down from last year.
  • As of Q4 2025, Sanofi's Other Operating Expenses stood at -$5.2 billion, which was down 4582.74% from -$3.8 billion recorded in Q3 2025.
  • In the past 5 years, Sanofi's Other Operating Expenses ranged from a high of -$656.2 million in Q1 2024 and a low of -$5.2 billion during Q4 2025
  • Moreover, its 3-year median value for Other Operating Expenses was -$2.7 billion (2023), whereas its average is -$2.5 billion.
  • In the last 5 years, Sanofi's Other Operating Expenses crashed by 3257.02% in 2024 and then tumbled by 24797.26% in 2025.
  • Quarter analysis of 3 years shows Sanofi's Other Operating Expenses stood at -$2.7 billion in 2023, then tumbled by 32.57% to -$3.5 billion in 2024, then plummeted by 45.83% to -$5.2 billion in 2025.
  • Its Other Operating Expenses was -$5.2 billion in Q4 2025, compared to -$3.8 billion in Q3 2025 and -$869.9 million in Q1 2025.